🇺🇸 FDA
Patent

US 9486502

Methods of administering interferon gamma to absorb fluid from the subretinal space

granted A61KA61K38/217A61K9/0048

Quick answer

US patent 9486502 (Methods of administering interferon gamma to absorb fluid from the subretinal space) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/217, A61K9/0048, A61P, A61P27/02